TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Tong Ren Tang Technologies Co ( (HK:1666) ) has provided an update.
Tong Ren Tang Technologies Co. has announced the proposed renewal of its continuing connected transactions and the appointment of a new director. These developments are set to be discussed at an Extraordinary General Meeting (EGM) scheduled for December 30, 2025. The renewal of agreements and leadership changes are expected to impact the company’s operational strategies and governance, potentially influencing its market positioning and stakeholder relations.
The most recent analyst rating on (HK:1666) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Tong Ren Tang Technologies Co stock, see the HK:1666 Stock Forecast page.
More about Tong Ren Tang Technologies Co
Tong Ren Tang Technologies Co. is a joint stock company incorporated in the People’s Republic of China, operating in the pharmaceutical industry. The company is known for its production and distribution of traditional Chinese medicine products.
Average Trading Volume: 1,198,362
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.05B
Find detailed analytics on 1666 stock on TipRanks’ Stock Analysis page.